ETHOPHARMACOLOGICAL ANALYSIS OF THE EFFECTS OF PUTATIVE ANXIOGENIC AGENTS IN THE MOUSE ELEVATED PLUS-MAZE

被引:110
作者
RODGERS, RJ
COLE, JC
ABOUALFA, K
STEPHENSON, LH
机构
[1] Ethopharmacology Laboratory, Department of Psychology, University of Leeds, Leeds
关键词
ELEVATED PLUS-MAZE; ETHOLOGICAL ANALYSIS; ANXIOGENIC; FG; 7142; PENTYLENETETRAZOL; SODIUM LACTATE; ISOPROTERENOL MICE;
D O I
10.1016/0091-3057(95)00190-8
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The literature on the effects of anxiety-provoking agents in humans and animals is replete with inconsistent and contradictory findings as well as data that may have alternate explanations. To further our understanding in this area, ethological methods were used to assess in detail the effects of four putative anxiogenic agents in the murine elevated plus-maze test. Compounds studied were FG 7142 (1.25-10.0 mg/kg), pentylenetetrazol (PTZ; 1.875-30.0 mg/kg), isoproterenol (0.125-1.0 mg/kg), and sodium lactate (32.75-262.0 mg/kg). FG 7142 produced an anxiogenic-like profile at 10 mg/kg, an effect that could not be attributed to seizure activity or nonspecific behavioural suppression. PTZ exerted biphasic effects, with low doses (1.875-3.75 mg/kg) producing anxiolytic-like effects and high doses (20.0-30.0 mg/kg) anxiogenic-like effects. With the exception of the highest dose tested, which radically disrupted behavior, these effects of PTZ were also seen to be behaviorally specific. Although some minor behavioural changes were evident with sodium lactate and isoproterenol, neither compound altered anxiety-related measures under present test conditions. Data are discussed in relation to distinctions between anxiety and panic, and the nature of anxiety expressed in and detected by animal models.
引用
收藏
页码:805 / 813
页数:9
相关论文
共 64 条
[11]   ABSENCE OF INTRINSIC ANTAGONIST ACTIONS OF BENZODIAZEPINE ANTAGONISTS ON AN EXPLORATORY MODEL OF ANXIETY IN THE MOUSE [J].
CRAWLEY, JN ;
SKOLNICK, P ;
PAUL, SM .
NEUROPHARMACOLOGY, 1984, 23 (05) :531-537
[12]   ETHOPHARMACOLOGICAL ANALYSIS OF RAT BEHAVIOR ON THE ELEVATED PLUS-MAZE [J].
CRUZ, APM ;
FREI, F ;
GRAEFF, FG .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 49 (01) :171-176
[13]   COMPARATIVE EFFECTS OF VALPROATE, ANXIOLYTIC, OR ANXIOGENIC DRUGS ON THE LIGHT DARK AVERSION TEST [J].
DEANGELIS, L .
DRUG DEVELOPMENT RESEARCH, 1992, 25 (04) :331-338
[14]   3-(METHOXYCARBONYL)-AMINO-BETA-CARBOLINE, A SELECTIVE ANTAGONIST OF THE SEDATIVE EFFECTS OF BENZODIAZEPINES [J].
DECARVALHO, LP ;
VENAULT, P ;
POTIER, MC ;
DODD, RH ;
BROWN, CL ;
CHAPOUTHIER, G ;
ROSSIER, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 129 (03) :323-332
[15]   HETEROGENEITY OF CCK-B RECEPTORS INVOLVED IN ANIMAL-MODELS OF ANXIETY [J].
DERRIEN, M ;
MCCORTTRANCHEPAIN, I ;
DUCOS, B ;
ROQUES, BP ;
DURIEUX, C .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 49 (01) :133-141
[16]   SHOCK-INDUCED ULTRASONIC VOCALIZATION IN YOUNG-ADULT RATS - A MODEL FOR TESTING PUTATIVE ANTI-ANXIETY DRUGS [J].
DEVRY, J ;
BENZ, U ;
SCHREIBER, R ;
TRABER, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 249 (03) :331-339
[17]  
DOROW R, 1983, LANCET, V2, P98
[18]   PROCONVULSANT ACTION OF CGS 8216 [J].
FILE, SE .
NEUROSCIENCE LETTERS, 1983, 35 (03) :317-320
[19]  
FILE SE, 1992, BIOL COUN S, P25
[20]   CHRONIC TREATMENT WITH IMIPRAMINE DOES NOT REVERSE THE EFFECTS OF 3 ANXIOGENIC COMPOUNDS IN A TEST OF ANXIETY IN THE RAT [J].
FILE, SE ;
JOHNSTON, AL .
NEUROPSYCHOBIOLOGY, 1987, 17 (04) :187-192